Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ascendis Pharma Oncology Division A/s

Clinical trials sponsored by Ascendis Pharma Oncology Division A/s, explained in plain language.

Ascendis Pharma Oncology Division A/S ASND NASDAQ

Biopharmaceutical company focused on oncology therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Terminated 1

Experimental cancer drug trial halted early

Disease control Terminated

This early-stage trial tested an investigational drug called TransCon TLR7/8 agonist, alone or with the immunotherapy pembrolizumab, in people with advanced solid tumors that could not be cured by surgery or radiation. The study aimed to find a safe dose and check for side effect…

Phase: PHASE1, PHASE2 • Sponsor: Ascendis Pharma Oncology Division A/S • Aim: Disease control

Last updated Jun 27, 2026 12:06 UTC